Rapid advancements in genomics continue to reshape research, diagnostics, agricultural science, precision medicine, and biotechnology. At the center of this progress is the DNA sequencer, a cornerstone of modern genetic analysis. Laboratories now depend on sequencing platforms for everything from whole-genome sequencing to targeted mutation analysis, requiring tools that balance speed, precision, accuracy, and cost.
As demand for high-quality sequencing expands, selecting the right system has become a strategic decision for research centers and clinical facilities. With multiple manufacturers offering specialized technologies, understanding the strengths of each brand helps labs make informed decisions based on workflow needs, sample volumes, and long-term goals.
This guide compares four of the most influential names in sequencing technology—Illumina, Thermo Fisher Scientific, Agilent Technologies, and Pacific Biosciences (PacBio). Each company approaches sequencing differently, giving laboratories options that range from high-throughput machines to long-read instruments and targeted platforms.
Understanding DNA Sequencers and Their Core Function
A DNA Sequencer is a specialized instrument that determines the order of nucleotides—adenine (A), thymine (T), cytosine (C), and guanine (G)—in a DNA molecule. Sequencing helps researchers analyze genetic variations, identify biomarkers, characterize microbial communities, and support diagnostics for hereditary and infectious diseases.
Modern DNA analysis equipment has evolved far beyond early Sanger sequencing. Today’s instruments use sophisticated chemistries, optics, microfluidics, and data-processing algorithms to generate millions to billions of reads with exceptional accuracy. Depending on technology, platforms vary in throughput, read length, cost per sample, run time, and compatibility with various applications.
Sequencers now support a broad range of tasks:
- Whole-genome and whole-exome sequencing
- Single-cell sequencing
- Targeted gene panels
- Transcriptomics and RNA sequencing
- Epigenetic profiling
- Metagenomics
- Structural variant analysis
- Microbial identification
- Oncology and clinical diagnostics
Because each research program requires different performance metrics, choosing the right system is essential.
Illumina – The Industry Standard for High-Throughput NGS
Illumina remains the global leader in next-generation sequencing (NGS). Its sequencing-by-synthesis (SBS) technology is known for exceptional accuracy, scalability, and broad application compatibility. Illumina systems dominate both research and clinical genomics due to their cost-effectiveness per base and strong data quality.
Key Strengths of Illumina Sequencers
1. High throughput: Systems like the NovaSeq, NextSeq, and MiSeq support a wide spectrum of sample volumes, from single-target runs to population-scale sequencing.
2. Low error rates: SBS chemistry provides exceptional data precision, making Illumina a preferred choice for researchers who require high-quality reads.
3. Versatile applications: The platform supports everything from small RNA sequencing to whole-genome sequencing and metagenomic studies.
4. Strong ecosystem: Library prep kits, bioinformatics pipelines, and partner integrations are widely available.
Ideal For: High-throughput genomics labs, clinical NGS workflows, academic research facilities, biotech companies, and population-scale genomic initiatives.
Thermo Fisher Scientific – Flexibility Across Applications
Thermo Fisher is known for providing broad genomic solutions supported by two main sequencing technologies: Ion Torrent semiconductor sequencing and Sanger sequencing instruments. This flexibility makes Thermo Fisher systems suitable for labs needing a mix of workflow types and sequencing depths.
Key Strengths of Thermo Fisher Sequencers
1. Ion Torrent semiconductor technology: Eliminates optical systems and uses chemical detection, resulting in faster run times.
2. Scalable system lineup: From Ion GeneStudio to Genexus, Thermo Fisher covers targeted panels, microbial sequencing, oncology applications, and rapid turnaround clinical workflows.
3. Strong clinical diagnostics orientation: Thermo Fisher offers FDA-cleared assays, sample-to-answer solutions, and integrated reporting tools.
4. Established Sanger platforms: Capillary electrophoresis sequencers like the 3500 series remain crucial for targeted sequencing and confirmation testing.
Ideal For: Clinical laboratories, targeted sequencing applications, infectious disease testing, oncology workflows, and teams needing rapid results.
Agilent Technologies – Precision and Quality for Targeted Analysis
Agilent is best known for its Sanger sequencing and microarray technologies, as well as its high-performance DNA analysis tools. While Agilent does not operate in high-throughput NGS sequencing, the brand remains a trusted name in targeted DNA workflows and quality analysis.
Key Strengths of Agilent Sequencing Solutions
1. Gold-standard Sanger sequencing: Agilent’s SureSelect target enrichment tools pair well with Sanger-based sequencing platforms.
2. Targeted DNA analysis excellence: Agilent focuses heavily on supporting high-accuracy gene panels, mutation analysis, and targeted assays.
3. Integration with broader instrumentation: Agilent’s genomic kits, microarrays, and analysis tools complement sequencing workflows from multiple brands.
4. Strong quality control tools: Agilent TapeStation, Bioanalyzer, and Femto Pulse instruments are essential for validating samples before sequencing.
Ideal For: Labs performing targeted analysis, confirmation sequencing, quality control workflows, and smaller-scale genomics research.
Pacific Biosciences (PacBio) – Long-Read Innovation
PacBio pioneered Single Molecule, Real-Time (SMRT) sequencing, a long-read technology that provides unparalleled accuracy over extended read lengths. PacBio systems excel in structural variant detection, full-length isoform analysis, and de novo sequencing.
Key Strengths of PacBio Sequencers
1. True long-read sequencing: Read lengths can exceed 15–20 kb on average, with some runs producing reads over 100 kb.
2. Exceptional accuracy: PacBio’s HiFi reads combine long-read capability with high accuracy, reducing assembly errors.
3. Superior structural variant and isoform characterization: Long reads capture areas of the genome that short-read systems cannot resolve.
4. Rapid expansion of applications: From plant genomics to rare-disease research, PacBio is becoming a core option for teams needing deeper genomic insight.
Ideal For: Structural variant research, metagenomics, full-length transcript sequencing, de novo genome assembly, and hybrid sequencing strategies combining long and short reads.
Comparative Summary: Key Metrics at a Glance
Below is a simplified comparison of how Illumina, Thermo Fisher, Agilent, and PacBio differ across several categories.
Category | Illumina | Thermo Fisher Scientific | Agilent Technologies | Pacific Biosciences (PacBio) |
Primary Technology | Sequencing-by-Synthesis (SBS) | Ion Torrent semiconductor + Sanger | Sanger sequencing + targeted analysis tools | SMRT (Single Molecule, Real-Time) sequencing |
Read Length | Short reads (50–300 bp) | Short to mid-range reads | Long targeted Sanger reads | Long reads (HiFi 15–20 kb avg, 100 kb+ max) |
Throughput | Highest throughput in the industry | Moderate to high, depending on the system | Not focused on high-throughput NGS | Moderate to high with long-read capability |
Accuracy | Very high accuracy with low error rates | High for targeted panels; variable depending on chemistry | High accuracy for targeted sequencing | Exceptional accuracy with HiFi reads |
Best Use Cases | Whole-genome sequencing, transcriptomics, metagenomics, and large-scale studies | Clinical diagnostics, targeted panels, infectious disease testing, oncology | Targeted sequencing, gene panels, QC workflows | Structural variant analysis, de novo assembly, full-length transcriptomics |
Data Output | Large read volumes; ideal for large-scale genomics | Fast turnaround; efficient for smaller panels | Smaller targeted datasets | Highly informative long-read datasets |
Cost per Sample | Low for large batches | Moderate, depending on workflow | Lower for targeted applications | Higher per sample but unmatched for long-read accuracy |
Bioinformatics Ecosystem | Extensive tools, pipelines, and support | Strong clinical reporting and analysis tools | Broad QC and targeted analysis tools | Specialized long-read analysis software |
Strengths | Scalability, accuracy, large application range | Flexibility, rapid runs, clinical focus | Precision, QC excellence, targeted sequencing strengths | Structural clarity, long-read precision |
Limitations | Short-read limitations for structural variants | Less suitable for large-scale WGS compared to Illumina | Not a comprehensive NGS provider | Higher cost; longer run times |
Certified Pre-Owned DNA Sequencers: Performance Meets Affordability
High-performance sequencers often require significant capital investment, which can limit accessibility for smaller labs, startups, and growing research groups. Certified pre-owned genetic analysis instruments offer a cost-effective solution without compromising on performance.
With rigorous refurbishment and validation, certified sequencers deliver strong reliability at reduced cost. Labs benefit from access to leading technologies—such as Illumina NextSeq, MiSeq, Thermo Fisher Ion Torrent, or PacBio Sequel, while conserving budget for consumables, new projects, and automation upgrades.
Additional advantages include:
- Warranty and service support
- Verified component reliability
- Calibration and accuracy testing
- Integration guidance for LIMS and workflow software
- Faster acquisition timelines compared to new units
For many facilities, certified pre-owned purchases make advanced sequencing accessible without reducing scientific output or data quality.
Choosing the Right Sequencer for Your Lab’s Goals
Selecting the right platform requires a clear understanding of workflow demands, sample volume, read-length requirements, and long-term research goals. Considerations include:
1. Throughput needs: Large-scale genomics programs benefit from Illumina, while targeted workflows may lean toward Thermo Fisher or Agilent.
2. Read length requirements: If long reads are essential, PacBio is the most suitable option.
3. Budget considerations: Certified pre-owned systems offer strong performance at a lower cost.
4. Downstream analysis requirements: Different platforms have distinct informatics ecosystems.
5. Scalability: Labs with dynamic workloads may require modular or multi-instrument strategies.
Align sequencing capabilities with anticipated research direction to maximize long-term ROI.
Smart Choices for Smarter Genomics
The right sequencing platform depends on the balance of accuracy, throughput, scalability, and budget. Whether your lab prioritizes high-throughput short reads, rapid targeted analysis, or long-read structural clarity, each brand—Illumina, Thermo Fisher, Agilent, and PacBio, brings unique strengths to the table. For labs looking to invest wisely, certified pre-owned DNA analysis machine options offer the reliability of OEM technology at a more accessible cost.
Copia Scientific delivers certified pre-owned sequencing solutions backed by rigorous validation, strong support, and dependable performance. Build a smarter genomics workflow today. Contact us to get started.
Author
Christin Smith
Christin Smith is a highly accomplished sales professional with nearly 30 years of experience, including the last 14 years in the biotech industry, specializing in capital equipment sales... Read more